share_log

Trulieve Cannabis Analyst Ratings

Trulieve Cannabis Analyst Ratings

Trulieve 大麻分析師評級
Benzinga ·  2023/08/11 22:44
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/11/2023 44.92% Wedbush $8 → $6 Maintains Outperform
08/10/2023 117.39% Needham $10 → $9 Maintains Buy
05/10/2023 141.54% Needham $12 → $10 Maintains Buy
03/09/2023 189.85% Needham $14.25 → $12 Maintains Buy
03/09/2023 793.7% Cantor Fitzgerald $41 → $37 Maintains Overweight
03/06/2023 890.31% Cantor Fitzgerald $51 → $41 Maintains Overweight
12/02/2022 334.77% Wedbush → $18 Initiates Coverage On → Outperform
11/10/2022 1131.85% Cantor Fitzgerald $54 → $51 Maintains Overweight
08/11/2022 1204.32% Cantor Fitzgerald $57 → $54 Maintains Overweight
07/22/2022 455.54% Seaport Global → $23 Initiates Coverage On → Buy
05/13/2022 1276.78% Cantor Fitzgerald $59 → $57 Maintains Overweight
03/31/2022 1035.24% Needham $50 → $47 Maintains Buy
03/29/2022 1349.24% Cantor Fitzgerald $72 → $60 Maintains Overweight
02/18/2022 1107.7% Needham $54 → $50 Maintains Buy
01/07/2022 Wolfe Research Initiates Coverage On → Outperform
12/06/2021 1639.09% Cantor Fitzgerald $73 → $72 Maintains Overweight
11/03/2021 1663.24% Cantor Fitzgerald $77 → $73 Maintains Overweight
09/22/2021 1856.47% Cantor Fitzgerald $50.5 → $81 Maintains Overweight
08/05/2021 1548.51% Needham $62.25 → $68.25 Maintains Buy
07/07/2021 1397.55% Jefferies → $62 Initiates Coverage On → Buy
05/14/2021 1614.93% Cantor Fitzgerald $76 → $71 Maintains Overweight
05/10/2021 1735.7% Cantor Fitzgerald $89 → $76 Maintains Overweight
04/30/2021 2049.71% Cantor Fitzgerald $83 → $89 Maintains Overweight
03/24/2021 1367.36% Needham $60.5 → $60.75 Maintains Buy
02/04/2021 1349.24% Roth Capital → $60 Initiates Coverage On → Buy
11/17/2020 1421.7% Cantor Fitzgerald $60 → $63 Maintains Overweight
09/17/2020 1349.24% Cantor Fitzgerald $59 → $60 Maintains Overweight
08/04/2020 606.5% Needham $18.2 → $29.25 Maintains Buy
06/30/2020 1156.01% Cantor Fitzgerald $50 → $52 Maintains Overweight
05/21/2020 339.6% Needham $17.2 → $18.2 Maintains Buy
05/13/2020 315.45% Needham $15.5 → $17.2 Maintains Buy
04/09/2020 274.39% Needham $15.25 → $15.5 Maintains Buy
04/06/2020 624.62% Cantor Fitzgerald $32 → $30 Maintains Overweight
03/23/2020 268.35% Needham $20 → $15.25 Maintains Buy
02/14/2020 624.62% Cantor Fitzgerald → $30 Initiates Coverage On → Overweight
12/16/2019 383.08% Craig-Hallum → $20 Initiates Coverage On → Buy
12/03/2019 383.08% Needham → $20 Initiates Coverage On → Buy
12/02/2019 310.62% Compass Point $11 → $17 Upgrades Neutral → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年08月11日 44.92% 韋德布什 $8→$6 維護 跑贏大盤
2023年08月10日 117.39% 李約瑟 $10→$9 維護
2023年05月10日 141.54% 李約瑟 $12→$10 維護
03/09/2023 189.85% 李約瑟 $14.25→$12 維護
03/09/2023 793.7% 康託·菲茨傑拉德 $41→$37 維護 超重
03/06/2023 890.31% 康託·菲茨傑拉德 $51→$41 維護 超重
12/02/2022 334.77% 韋德布什 →$18 開始承保 →跑贏大盤
2022年11月10日 1131.85% 康託·菲茨傑拉德 $54→$51 維護 超重
2022年08月11日 1204.32% 康託·菲茨傑拉德 $57→$54 維護 超重
07/22/2022 455.54% 環球海港 →$23 開始承保 →購買
2022年05月13日 1276.78% 康託·菲茨傑拉德 $59→$57 維護 超重
03/31/2022 1035.24% 李約瑟 $50→$47 維護
03/29/2022 1349.24% 康託·菲茨傑拉德 $72→$60 維護 超重
02/18/2022 1107.7% 李約瑟 $54→$50 維護
01/07/2022 - 沃爾夫研究 開始承保 →跑贏大盤
12/06/2021 1639.09% 康託·菲茨傑拉德 $73→$72 維護 超重
11/03/2021 1663.24% 康託·菲茨傑拉德 $77→$73 維護 超重
09/22/2021 1856.47% 康託·菲茨傑拉德 $50.5→$81 維護 超重
08/05/2021 1548.51% 李約瑟 $62.25→$68.25 維護
07/07/2021 1397.55% 傑富瑞 →$62 開始承保 →購買
2021/05/14 1614.93% 康託·菲茨傑拉德 $76→$71 維護 超重
2021/05/10 1735.7% 康託·菲茨傑拉德 $89→$76 維護 超重
04/30/2021 2049.71% 康託·菲茨傑拉德 $83→$89 維護 超重
03/24/2021 1367.36% 李約瑟 $60.5→$60.75 維護
02/04/2021 1349.24% 羅斯資本 →$60 開始承保 →購買
11/17/2020 1421.7% 康託·菲茨傑拉德 $60→$63 維護 超重
09/17/2020 1349.24% 康託·菲茨傑拉德 $59→$60 維護 超重
08/04/2020 606.5% 李約瑟 $18.2→$29.25 維護
06/30/2020 1156.01% 康託·菲茨傑拉德 $50→$52 維護 超重
2020/05/21 339.6% 李約瑟 $17.2→$18.2 維護
2020/05/13 315.45% 李約瑟 $15.5→$17.2 維護
04/09/2020 274.39% 李約瑟 $15.25→$15.5 維護
04/06/2020 624.62% 康託·菲茨傑拉德 $32→$30 維護 超重
03/23/2020 268.35% 李約瑟 $20→$15.25 維護
02/14/2020 624.62% 康託·菲茨傑拉德 →$30 開始承保 →超重
2019年12月16日 383.08% 克雷格-哈勒姆 →$20 開始承保 →購買
2019/12/03 383.08% 李約瑟 →$20 開始承保 →購買
2019年2月12日 310.62% 指南針 $11→$17 升級 中性→購買

What is the target price for Trulieve Cannabis (TCNNF)?

Trulieve Cannabis的目標價格是多少?

The latest price target for Trulieve Cannabis (OTCQX: TCNNF) was reported by Wedbush on August 11, 2023. The analyst firm set a price target for $6.00 expecting TCNNF to rise to within 12 months (a possible 44.92% upside). 8 analyst firms have reported ratings in the last year.

韋德布什於2023年8月11日報道了Trulieve Cannabis(OTCQX:TCNNF)的最新目標價。這家分析公司將目標價定為6美元,預計TCNNF將在12個月內上漲至44.92%(可能上漲44.92%)。去年有8家分析公司公佈了評級。

What is the most recent analyst rating for Trulieve Cannabis (TCNNF)?

Trulieve Cannabis(TCNNF)的最新分析師評級是多少?

The latest analyst rating for Trulieve Cannabis (OTCQX: TCNNF) was provided by Wedbush, and Trulieve Cannabis maintained their outperform rating.

韋德布什提供了對Trulieve Cannabis(場外交易市場代碼:TCNNF)的最新分析師評級,Trulieve Cannabis維持了其表現優於大盤的評級。

When is the next analyst rating going to be posted or updated for Trulieve Cannabis (TCNNF)?

Trulieve Cannabis(TCNNF)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Trulieve Cannabis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Trulieve Cannabis was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Trulieve Cannabis的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Trulieve大麻的上一次評級是在2023年8月11日提交的,所以你應該預計下一次評級將在2024年8月11日左右提供。

Is the Analyst Rating Trulieve Cannabis (TCNNF) correct?

分析師評級Trulieve Cannabis(TCNNF)正確嗎?

While ratings are subjective and will change, the latest Trulieve Cannabis (TCNNF) rating was a maintained with a price target of $8.00 to $6.00. The current price Trulieve Cannabis (TCNNF) is trading at is $4.14, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Trulieve Cannabis(TCNNF)評級維持不變,目標價在8.00美元至6.00美元之間。Trulieve Cannabis(TCNNF)目前的交易價格為4.14美元,超出了分析師的預測區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論